Google News – Pharmaceuticals External News
Life Sciences & Pharma Articles
Google News – Pharmaceuticals External News
ANI Pharmaceuticals CFO Sells $240,000 in Stock After a 42% Cortrophin Surge - The Motley Fool
Google News – Pharmaceuticals External News
Is Recursion Pharmaceuticals (RXRX) The Best Penny Stocks According to Billioanires? - Yahoo Finance
Google News – Pharmaceuticals External News
Is Regeneron Pharmaceuticals, Inc. (REGN) Stock Still a Biotech Leader After Analyst Price Target Cut? - Yahoo Finance
Google News – Biopharma External News
Teva and Polpharma Biologics Ink Global Biosimilar Agreement - Contract Pharma
Google News – Biopharma External News
WuXi Biologics Drug Substance Manufacturing Facility Passes FDA Pre-License Inspection - Contract Pharma
Google News – Biopharma External News
West Launches Synchrony™ Prefillable Syringe System for Biologics and Vaccines in Southeast Asia - BioPharma APAC
Google News – Biopharma External News
Oppenheimer initiates Connect Biopharma stock with outperform rating By Investing.com - Investing.com Canada
Google News – Biopharma External News
Emerging Therapies Transforming the Myasthenia Gravis Market by DelveInsight | Sanofi, Cartesian Therapeutics, Takeda, UCB Biopharma, Roche, Janssen R&D, Immunovant Sciences GmbH, Argenx-Halozyme - Barchart.com
Google News – Biopharma External News
Olon Completes Major Concord Facility Expansion - Contract Pharma
Google News – Biopharma External News
Form 4 Vor Biopharma Inc For: 9 July By Investing.com - Investing.com Canada
Google News – Biopharma External News
South Korea Biopharma Exports Hit Record High - Businesskorea
Google News – Biopharma External News
Arbutus Biopharma stock hits 52-week high at 5.34 USD By Investing.com - Investing.com Canada
Google News – Biopharma External News
THERAVANCE BIOPHARMA ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY ZYMEWORKS FOR $17.00 PER SHARE IN CASH PLUS A CONTINGENT VALUE RIGHT - PR Newswire
Google News – Biopharma External News